Organic nitrate reductase: reassessment of its subcellular localization and tissue distribution and its relationship to the glutathione transferases

The International Journal of Biochemistry
I W TaylorD V Parke


1. Using a specific and sensitive GLC method for the determination of glyceryl trinitrate (GTN), its subcellular and tissue distribution were reassessed. Liver was the most active tissue, but activity was also detected in the heart, kidney and gut. In all tissues activity was localized in the soluble fraction. The activity of soluble glutathione S-transferase followed the same pattern, liver exhibiting the highest and the heart the lowest activity. 2. Pretreatment with phenobarbitone and 3-methylcholanthrene stimulated both the glutathione S-transferase and organic nitrate reductase activities. 3. Glutathione S-transferase activity was competitively inhibited by GTN. 4. A comparison of the plasma and hepatic metabolism of GTN revealed higher drug affinity for the hepatic enzyme.


Jun 1, 1978·Archives of Biochemistry and Biophysics·C J MarcusW B Jakoby
Mar 1, 1979·Circulation·P W ArmstrongG S Marks
Oct 1, 1975·The Journal of Pharmacy and Pharmacology·C Ioannides, D V Parke
Jan 15, 1977·Biochemical Pharmacology·R D ShortC C Lee
Jan 1, 1976·Annual Review of Pharmacology and Toxicology·P Needleman
Apr 1, 1970·Biochemical Pharmacology·F J DiCarlo, M D Melgar
Aug 1, 1965·Biochemical Pharmacology·P Needleman, J C Krantz
Jul 1, 1984·Journal of Pharmaceutical Sciences·H L FungG A Maier
Sep 1, 1982·British Journal of Pharmacology·C IoannidesI W Taylor


Apr 27, 2005·British Journal of Pharmacology·L Christofer AddingLars E Gustafsson
Mar 15, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Modesto de CandiaCosimo D Altomare
Jan 21, 2006·The Journal of Pharmacology and Experimental Therapeutics·Mirco GovoniPaola Tocchetti

Related Concepts

Enzyme Activation
Enzyme Induction

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Related Papers

The American Journal of Cardiology
J O Parker, H L Fung
Canadian Journal of Physiology and Pharmacology
B J McDonald, B M Bennett
© 2021 Meta ULC. All rights reserved